Form 4: Bausch & Lomb Exec Reports Share Transaction

Luc Bonnefoy, President of Surgical at Bausch & Lomb Corp, reported a transaction involving common shares on June 12, 2026.

Summary

• Luc Bonnefoy, President of Surgical at Bausch & Lomb Corp, reported a transaction on June 12, 2026.
• The transaction involved 1,008 common shares acquired at a price of $15.08 per share.
• These shares were withheld to cover tax obligations upon the vesting of restricted share units.
• Following this transaction, Bonnefoy beneficially owns 87,023 common shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard tax withholding event for executive compensation rather than a discretionary buy or sell decision.

Positives

• Luc Bonnefoy's direct beneficial ownership of 87,023 common shares indicates a significant personal stake in the company.
• The withholding of shares for tax purposes upon vesting of RSUs is a standard and expected event in executive compensation.

Negatives

• The transaction represents a disposition of shares to cover tax liabilities, which could be viewed as a reduction in direct holdings, although it's a standard procedure.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and are crucial for understanding executive alignment with shareholder interests. This filing from Bausch & Lomb Corp (BLCO) is typical for an executive managing tax obligations related to equity compensation.

Stakeholder Impact

• Shareholders: The transaction is a routine tax event and does not indicate a change in management's long-term commitment to the company. The direct ownership remains substantial.

Key Dates

Keywords

Bausch & Lomb Corp, BLCO, Form 4, Insider Trading, Executive Compensation, Restricted Share Units, Common Shares, Beneficial Ownership